To achieve safe security to transfer data from the sender to receiver, cryptography is one way that is used for such purposes. However, to increase the level of data security, DNA as a new term was introduced to cryptography. The DNA can be easily used to store and transfer the data, and it becomes an effective procedure for such aims and used to implement the computation. A new cryptography system is proposed, consisting of two phases: the encryption phase and the decryption phase. The encryption phase includes six steps, starting by converting plaintext to their equivalent ASCII values and converting them to binary values. After that, the binary values are converted to DNA characters and then converted to their equivalent complementary DNA sequences. These DNA sequences are converted to RNA sequences. Finally, the RNA sequences are converted to the amino acid, where this sequence is considered as ciphertext to be sent to the receiver. The decryption phase also includes six steps, which are the same encryption steps but in reverse order. It starts with converting amino acid to RNA sequences, then converting RNA sequences to DNA sequences and converting them to their equivalent complementary DNA. After that, DNA sequences are converted to binary values and to their equivalent ASCII values. The final step is converting ASCII values to alphabet characters that are considered plaintext. For evaluation purposes, six text files with different sizes have been used as a test material. Performance evaluation is calculated based on encryption time and decryption time. The achieved results are considered as good and fast, where the encryption and decryption times needed for a file with size of 1k are equal to 2.578 ms and 2.625 ms respectively, while the encryption and decryption times for a file with size of 20k are equal to 268.422 ms and 245.469 ms respectively.
(17)
(14)
(28)
(28)
(56)
(52)
(1)
(155)
(154)
(9)
(11)
Lasmiditan (LAS) was formulated as a nanoemulsion based in situ gel (NEIG)with the aim of improving its oral bioavailability via application intranasally. The solubility of LAS in oils, emulsifiers, and co-emulsifiers was determined to identify nanoemulsion (NE)components. Phase diagrams were constructed to identify the area of nanoemulsification. LAS NE was formulated using the spontaneous nanoemulsification method. Four NEs (F19, F24, F31, and F34) containing 7-15 % oleic acid (OA) as an oily phase, 40-55% labrasol (LR), and transcutol (TC) as emulsifier mixture at (1:1), (2:1), (3:1), and (1:2) ratio with 30-53 % (w/w) aqueous phase, having suitable optical transparency of 95–98%, globule size of 104-140 nm and polydisper
... Show More
(17)
(11)
(6)
tA novel synthesis procedure is presented for preparing triethanolamine-treated graphene nanoplatelets(TEA-GNPs) with different specific areas (SSAs). Using ultrasonication, the covalently functionalizedTEA-GNPs with different weight concentrations and SSAs were dispersed in distilled water to prepareTEA-GNPs nanofluids. A simple direct coupling of GNPs with TEA molecules is implemented to synthesizestable water-based nanofluids. The effectiveness of the functionalization procedure was validated by thecharacterization and morphology tests, i.e., FTIR, Raman spectroscopy, EDS, and TEM. Thermal conduc-tivity, dispersion stability, and rheological properties were investigated. Using UV–vis spectrometer, ahighest dispersion stability of 0.876
... Show More
(97)
(26)
(23)